References
- HuangYTHsuehPRAntimicrobial drug resistance in TaiwanInt J Antimicrob Agents200832Suppl 3S174S17819013350
- LinKYLauderdaleTLWangJTChangSCCarbapenem-resistant Pseudomonas aeruginosa in Taiwan: prevalence, risk factors, and impact on outcome of infectionsJ Microbiol Immunol Infect2016491525924662016
- KuoHYWangFDYenYFLinMLLiuCYIn vitro activities of piperacillin or cefoperazone alone and in combination with beta-lactamase inhibitors against Gram-negative bacilliNew Microbiol2009321495519382669
- LaiCCChenCCLuYCLinTPChuangYCTangHJAppropriate composites of cefoperazone-sulbactam against multidrug-resistant organismsInfect Drug Resist2018111441144530237728
- ChangPCChenCCLuYCThe impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organismsJ Microbiol Immunol Infect201851220721329037802
- LaiCCChenCCHuangHLChuangYCTangHJThe role of doxy-cycline in the therapy of multidrug-resistant E. coli – an in vitro studySci Rep201663196427534373
- Clinical and Laboratory Standards InstituteMethods for Dilution Antimicrobial Susceptibility Testing of Bacteria that Grow Aerobically; Approved Standard8th ed CLSI document M07-A9Wayne PACLSI2012
- LinYCHsiaKCChenYCGenetic basis of multidrug resistance in Acinetobacter clinical isolates in TaiwanAntimicrob Agents Chemother20105452078208420194701
- MoubareckCBrémontSConroyMCCourvalinPLambertTGES-11, a novel integron-associated GES variant in Acinetobacter baumanniiAntimicrob Agents Chemother20095383579358119451292
- KaoCYChenSSHungKHOverproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in TaiwanBMC Microbiol201616110727296461
- JeonJHLeeJHLeeJJStructural basis for carbapenem-hydrolyzing mechanisms of carbapenemases conferring antibiotic resistanceInt J Mol Sci20151659654969225938965
- SenBJoshiSGStudies on Acinetobacter baumannii involving multiple mechanisms of carbapenem resistanceJ Appl Microbiol2016120361962926709119
- KuoSCLeeYTYang LauderdaleTLContribution of Acinetobacter-derived cephalosporinase-30 to sulbactam resistance in Acinetobacter baumanniiFront Microbiol2015623126284030
- AkovaMSulbactam-containing beta-lactamase inhibitor combinationsClin Microbiol Infect200814Suppl 118518818154545
- ChaudharyMPayasiAPrevalence, genotyping of Escherichia coli and Pseudomonas aeruginosa clinical isolates for oxacillinase resistance and mapping susceptibility behaviorJ Microb Biochem Technol201466367